Alabama: Alabama has two bills related to psychoactive hemp products in Senate committees. SB 273 is in the Business and Industry Committee, and SB 274 is in the Health and Social Services Committee.
Florida: Hemp regulation bill SB 438, which would ban all Delta-8 products and limit the amount of Delta-9 hemp-derived products to no more than five milligrams per serving or 50 milligrams per container, passed unanimously in the Florida Senate.
Georgia: SR 427, which establishes a Senate Study Committee on intoxicating cannabinoids in high-THC hemp-derived products, passed this session. This study committee will promote a thorough gathering of knowledge on this complex scientific and policy issue, producing a report that will recommend how to close significant aspects of the hemp loophole in Georgia. No pro-marijuana/THC/hemp legislation––such as HB 220, HR 227, and SB 254S––passed this session.
Indiana: SB 478, which would have risked public health and safety by legalizing and normalizing dangerous THC drugs, did not get final approval from the legislature. Read more here.
Nebraska: A bill to regulate medical marijuana in the state, LB 677, stalled in an executive session in the Legislature’s General Affairs Committee. Learn more here.
New Hampshire: The New Hampshire Senate Judiciary Committee voted against House Bill 198, which would have legalized certain quantities of marijuana, citing public safety concerns. Read more here.
New Jersey: On the third anniversary of state commercial marijuana sales, data released by the state’s police makes it clear: legalization has made the roads significantly more dangerous. Learn more here.
New York: Four years after the signing of New York’s Marijuana Regulation and Taxation Act (MRTA) it’s abundantly clear that the state’s embrace of pot profiteers has been anything but safe and isn’t fulfilling any of those promises. Learn more here.